RMI Nuclear Justice Documents

Table 4 (cont'd) Patient No. & sex Age at surgery Years post exposure Pathologic diagnosis Remarks Utirik exposed 2229 F 32 15 1/2 Follicular carcinoma 2208 F 2212 F 53 53 19 19 2221 F 73 19 Adenomatous nodules Adenomatous nodules with Hurthle cell adenoma Adenomatous nodules 2160 F 2150 M 2194 F 2261x M 25 34 59 50 21 1/2 22 22 23 1/2 Papillary carcinoma Follicular adenoma Papillary carcinoma No diagnostic lesion (2193 F 2195 F 2215 F 56 49 58 25 1/2 25 1/2 25 1/2 Adenomatous nodules Papillary hyperplasia Adenomatous nodule Adenomatous nodules with occult papillary 2147 F 2196 F 30 63 25 1/2 26 1/2 Adenomatous nodules Adenomatous nodules 2236 M 2239 F 2132 F 35 29 28 24 27 27 with follicular adenoma Follicular adenoma carcinoma Adenomatous nodules Adenomatous nodule Divided opinion: atypical adenoma Hyperplasia Hyperplasia, atypia focal Hyperplasia Lymph node metastases Focal hyperplasia Diffuse Fibrosis Rongelap unexposed controls 938 F 33 Adenomatous nodule 841 F 4} Adenomatous nodules 1007 M 1573 M 66 28 829 F 867 F 4023 F 1556 F 4] 50 44 34 Adenomatous nodule Papillary hyperplasia with occult papillary carcinoma Papillary carcinoma Fibrosis, hyperplasia Papillary carcinoma Adenomatous nodule Adenomatous nodule No dlagnostic lesion -65- Fibrosis Papillary hyperplasia